BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18155831)

  • 21. [Effects of hFRNK on E-cadherin/beta-catenin in colon cancer cells in vitro].
    Cao J; Yu JP; Liu CH; Chen XW; Liu S; Luo HS; Yu HG
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):346-50. PubMed ID: 17892129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of E-cadherin endocytosis by loss of protein phosphatase 2A expression in human breast cancers.
    Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2006 Oct; 349(1):255-60. PubMed ID: 16930554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells.
    Kocher HM; Sandle J; Mirza TA; Li NF; Hart IR
    Gut; 2009 Feb; 58(2):271-84. PubMed ID: 18852256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells.
    Mao Q; Li Y; Zheng X; Yang K; Shen H; Qin J; Bai Y; Kong D; Jia X; Xie L
    Biochem Biophys Res Commun; 2008 Oct; 375(4):566-70. PubMed ID: 18725195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9.
    Zhou B; Leng J; Hu M; Zhang L; Wang Z; Liu D; Tong X; Yu B; Hu Y; Deng C; Liu Y; Zhang Q
    Leuk Res; 2010 Jun; 34(6):769-76. PubMed ID: 20036004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of shRNA-CXCR4 on breast cancer cells migration and invasion].
    Li HY; Ren GS; Tan JX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):393-7. PubMed ID: 19626989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.
    Ling X; Arlinghaus RB
    Cancer Res; 2005 Apr; 65(7):2532-6. PubMed ID: 15805244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
    Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
    Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance.
    Escaffit F; Perreault N; Jean D; Francoeur C; Herring E; Rancourt C; Rivard N; Vachon PH; Paré F; Boucher MP; Auclair J; Beaulieu JF
    Exp Cell Res; 2005 Jan; 302(2):206-20. PubMed ID: 15561102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of Ezrin in gastric carcinoma and its significance].
    Shi RL; Li JF; Qu Y; Chen XH; Gu QL; Zhu ZG; Liu BY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):433-5. PubMed ID: 17043968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
    J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
    Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
    Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells.
    Stasinopoulos I; O'Brien DR; Wildes F; Glunde K; Bhujwalla ZM
    Mol Cancer Res; 2007 May; 5(5):435-42. PubMed ID: 17510310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.